HHV-8-associated MCD: Difference between revisions
CSV import |
CSV import |
||
| Line 25: | Line 25: | ||
[[Category:Viral diseases]] | [[Category:Viral diseases]] | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:BX2306-20-12043-01-HHV8-06@40x (Enfermedad de Castleman multicéntrica asociada a HHV8 y sarcoma de Kaposi).jpg|HHV-8-associated MCD | |||
File:Kaposi sarcoma in a patient with HHV8-associated MCD.jpg|HHV-8-associated MCD | |||
</gallery> | |||
Revision as of 00:52, 20 February 2025
HHV-8-associated MCD is a rare, non-cancerous lymphoproliferative disorder that is associated with the Human Herpesvirus 8 (HHV-8). This condition is characterized by the overgrowth of lymphocytes, a type of white blood cell, in the lymph nodes.
Symptoms
The symptoms of HHV-8-associated MCD can vary widely, but often include fever, night sweats, weight loss, and fatigue. Some patients may also experience abdominal pain, nausea, and vomiting due to enlargement of the spleen or liver.
Causes
HHV-8-associated MCD is caused by an infection with the Human Herpesvirus 8. This virus is also known to cause Kaposi's sarcoma, a type of cancer that can affect the skin, mouth, and internal organs.
Diagnosis
The diagnosis of HHV-8-associated MCD is typically made through a combination of physical examination, blood tests, and imaging studies. In some cases, a biopsy of the affected lymph node may be necessary to confirm the diagnosis.
Treatment
The treatment of HHV-8-associated MCD typically involves the use of antiviral medications to control the HHV-8 infection, as well as immunomodulatory drugs to reduce the overgrowth of lymphocytes. In severe cases, chemotherapy may be necessary.
Prognosis
The prognosis for patients with HHV-8-associated MCD can vary widely, depending on the severity of the disease and the patient's overall health. However, with appropriate treatment, many patients can achieve a good quality of life.
.jpg)
